Literature DB >> 20687780

Prevalence of angiotensin-converting enzyme, methylenetetrahydrofolate reductase, Factor V Leiden, prothrombin and apolipoprotein E gene polymorphisms in Morocco.

Thierry Paluku They-They1, Khalil Hamzi, Mohamed Taha Moutawafik, Hanane Bellayou, Mariame El Messal, Sellama Nadifi.   

Abstract

BACKGROUND: Evidence of the influence of genetic risk factors on cardiovascular diseases is more or less established. These genetic factors are involved in several pathways affecting blood pressure regulation, blood coagulation, homocysteine and lipid metabolisms. AIM: We evaluated frequencies of five genetic polymorphisms to assess their informativeness as markers for prospective clinical studies. SUBJECTS AND METHODS: 182 healthy Moroccan subjects were genotyped for ACE I/D by amplification alone and by amplification followed by enzymatic digestion for other polymorphisms.
RESULTS: Allele frequencies of ACE ID, MTHFR C677T were 76.6%, 26.9% for D and T alleles, respectively. APOE polymorphism showed 11.3%, 78.6% and 10.2% for the alleles E2, E3 and E4, respectively. The frequency for FII G20210A polymorphism was around 2.7% for A allele. Our data showed an absence of FVL mutation. Using allele frequencies, genetic distances between Moroccan and other populations revealed an independent variability of these polymorphisms.
CONCLUSION: These values appear to be influenced by findings in European and African peoples, and may be considered in assessing the clinical significance of a predisposition to cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20687780     DOI: 10.3109/03014461003738850

Source DB:  PubMed          Journal:  Ann Hum Biol        ISSN: 0301-4460            Impact factor:   1.533


  12 in total

1.  Prevalence of 1691G>A FV mutation in Poland compared with that in other Central, Eastern and South-Eastern European countries.

Authors:  Grażyna Adler; Jeremy S C Clark; Beata Loniewska; Ewa Czerska; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

2.  First study of the C2491t nonsense mutation frequency in moroccan healthy population.

Authors:  K Hamzi; B Diakité; W Hmimech; S Nadifi
Journal:  J Mol Neurosci       Date:  2013-06-15       Impact factor: 3.444

3.  First study of C2491T FV mutation with ischaemic stroke risk in Morocco.

Authors:  Brehima Diakite; Khalil Hamzi; Wiam Hmimech; Sellama Nadifi
Journal:  J Genet       Date:  2015-06       Impact factor: 1.166

4.  Prevalence of 1691G>A FV mutation in females from Bosnia and Herzegovina--a preliminary report.

Authors:  Amina Valjevac; Bakir Mehić; Emina Kiseljaković; Slavka Ibrulj; Agnieszka Garstka; Grażyna Adler
Journal:  Bosn J Basic Med Sci       Date:  2013-02       Impact factor: 3.363

5.  G2691A and C2491T mutations of factor V gene and pre-disposition to myocardial infarction in Morocco.

Authors:  Wiam Hmimech; Brehima Diakite; Hind Hassani Idrissi; Khalil Hamzi; Farah Korchi; Dalila Baghdadi; Rachida Habbal; Sellama Nadifi
Journal:  Biomed Rep       Date:  2016-09-30

6.  Prevalence of positive factor V Leiden and prothrombin mutations in samples tested for thrombophilia in Saudi Arabia.

Authors:  Fatimah Madkhaly; Abdulaziz Alshaikh; Hala Aba Alkhail; Randa Alnounou; Tarek Owaidah
Journal:  Am J Blood Res       Date:  2021-06-15

7.  Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-11-28       Impact factor: 2.576

8.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

9.  Diet, genetics, and disease: a focus on the middle East and north Africa region.

Authors:  Akl C Fahed; Abdul-Karim M El-Hage-Sleiman; Theresa I Farhat; Georges M Nemer
Journal:  J Nutr Metab       Date:  2012-03-29

10.  Allele frequency distribution of 1691G >A F5 (which confers Factor V Leiden) across Europe, including Slavic populations.

Authors:  Jeremy S C Clark; Grażyna Adler; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  J Appl Genet       Date:  2013-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.